Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 33.53% is 36% above its 5-year average of 24.72%, near the high end of its 5-year range (-0.60%–37.36%).
1.81% below its 12-month average of 34.15%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
33.53%
NET PROFIT MARGIN AVG TTM
34.15%
NET PROFIT MARGIN AVG 3Y
27.49%
NET PROFIT MARGIN AVG 5Y
24.72%
NET PROFIT MARGIN AVG 10Y
22.73%
NET PROFIT MARGIN AVG 15Y
19.86%
NET PROFIT MARGIN AVG 20Y
19.86%
CURRENT VS TTM AVG
-1.81%
CURRENT VS 3Y AVG
+21.95%
CURRENT VS 5Y AVG
+35.65%
CURRENT VS 10Y AVG
+47.53%
CURRENT VS 15Y AVG
+68.87%
CURRENT VS 20Y AVG
+68.83%
SECTOR MEDIAN · HEALTHCARE
8.98%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+273.39%
vs the sector median at left
Eli Lilly and Company
Market Cap
$1.06T
Net Profit Margin
33.53%
TTM Avg
34.15%
3Y Avg
27.49%
5Y Avg
24.72%
Market Cap
$647.80B
Net Profit Margin
21.48%
TTM Avg
22.15%
3Y Avg
27.00%
5Y Avg
25.39%
Market Cap
$364.36B
Net Profit Margin
4.78%
TTM Avg
27.40%
3Y Avg
19.98%
5Y Avg
20.62%
Market Cap
$354.70B
Net Profit Margin
3.14%
TTM Avg
3.15%
3Y Avg
4.63%
5Y Avg
5.09%
Market Cap
$342.57B
Net Profit Margin
20.33%
TTM Avg
16.80%
3Y Avg
17.87%
5Y Avg
19.70%
Market Cap
$245.15B
Net Profit Margin
17.02%
TTM Avg
15.23%
3Y Avg
12.72%
5Y Avg
10.53%
Market Cap
$225.75B
Net Profit Margin
15.06%
TTM Avg
14.95%
3Y Avg
14.84%
5Y Avg
16.47%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eli Lilly and Company (LLY) | $1.06T | 33.53% | 34.15% | 27.49% | 24.72% |
| Johnson & Johnson (JNJ)vs › | $647.80B | 21.48% | 22.15% | 27.00% | 25.39% |
| AbbVie Inc. (ABBV)vs › | $441.18B | 9.81% | 7.25% | 10.96% | 12.41% |
| Merck & Co., Inc. (MRK)vs › | $364.36B | 4.78% | 27.40% | 19.98% | 20.62% |
| UnitedHealth Group Incorporated (UNH)vs › | $354.70B | 3.14% | 3.15% | 4.63% | 5.09% |
| Roche Holding AG (RHHBY)vs › | $342.57B | 20.33% | 16.80% | 17.87% | 19.70% |
| AstraZeneca PLC (AZN)vs › | $245.15B | 17.02% | 15.23% | 12.72% | 10.53% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $225.75B | 15.06% | 14.95% | 14.84% | 16.47% |
| Amgen Inc. (AMGN)vs › | $212.27B | 22.93% | 16.61% | 20.49% | 22.20% |
| Novo Nordisk A/S (NVO)vs › | $199.51B | 35.33% | 33.96% | 33.83% | 33.74% |
Operating Margin
43.9%
Net Profit Margin
33.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 30.88% |
| 2026-03-31 | 37.36% |
| 2025-12-31 | 34.40% |
| 2025-09-30 | 31.72% |
| 2025-06-30 | 36.38% |
| 2025-03-31 | 21.68% |
| 2024-12-31 | 32.59% |
| 2024-09-30 | 8.48% |
| 2024-06-30 | 26.25% |
| 2024-03-31 | 25.58% |
| 2023-12-31 | 23.41% |
| 2023-09-30 | -0.60% |
| 2023-06-30 | 21.21% |
| 2023-03-31 | 19.32% |
| 2022-12-31 | 26.54% |
| 2022-09-30 | 20.91% |
| 2022-06-30 | 14.68% |
| 2022-03-31 | 24.36% |
| 2021-12-31 | 21.58% |
| 2021-09-30 | 16.39% |
| 2021-06-30 | 20.63% |
| 2021-03-31 | 19.91% |
| 2020-12-31 | 28.45% |
| 2020-09-30 | 21.05% |
| 2020-06-30 | 25.68% |
| 2020-03-31 | 24.86% |
| 2019-12-31 | 24.46% |
| 2019-09-30 | 22.90% |
| 2019-06-30 | 23.55% |
| 2019-03-31 | 83.30% |
| 2018-12-31 | 17.47% |
| 2018-09-30 | 21.66% |
| 2018-06-30 | -4.65% |
| 2018-03-31 | 24.53% |
| 2017-12-31 | -26.89% |
| 2017-09-30 | 9.82% |
| 2017-06-30 | 17.31% |
| 2017-03-31 | -2.12% |
| 2016-12-31 | 13.40% |
| 2016-09-30 | 14.99% |
| 2016-06-30 | 13.83% |
| 2016-03-31 | 9.05% |
| 2015-12-31 | 8.90% |
| 2015-09-30 | 16.12% |
| 2015-06-30 | 12.07% |
| 2015-03-31 | 11.40% |
| 2014-12-31 | 8.37% |
| 2014-09-30 | 10.27% |
| 2014-06-30 | 14.86% |
| 2014-03-31 | 15.54% |
| 2013-12-31 | 12.52% |
| 2013-09-30 | 20.84% |
| 2013-06-30 | 20.34% |
| 2013-03-31 | 27.63% |
| 2012-12-31 | 13.89% |
| 2012-09-30 | 24.37% |
| 2012-06-30 | 16.49% |
| 2012-03-31 | 18.05% |
| 2011-12-31 | 14.19% |
| 2011-09-30 | 20.11% |
| 2011-06-30 | 19.15% |
| 2011-03-31 | 18.08% |
| 2010-12-31 | 18.90% |
| 2010-09-30 | 23.04% |
| 2010-06-30 | 23.46% |
| 2010-03-31 | 22.75% |
| 2009-12-31 | 15.43% |
| 2009-09-30 | 16.93% |
| 2009-06-30 | 21.89% |
| 2009-03-31 | 26.02% |
| 2008-12-31 | -69.66% |
| 2008-09-30 | -8.94% |
| 2008-06-30 | 18.62% |
| 2008-03-31 | 22.14% |
| 2007-12-31 | 16.46% |
| 2007-09-30 | 20.19% |
| 2007-06-30 | 14.33% |
| 2007-03-31 | 12.04% |
| 2006-12-31 | 3.12% |
| 2006-09-30 | 22.61% |
| 2006-06-30 | 21.26% |
| 2006-03-31 | 22.47% |
| 2005-12-31 | 18.06% |
| 2005-09-30 | 22.06% |
| 2005-06-30 | -6.87% |
| 2005-03-31 | 21.06% |
| 2004-12-31 | -0.07% |
| 2004-09-30 | 23.02% |
| 2004-06-30 | 18.47% |
| 2004-03-31 | 11.86% |
| 2003-12-31 | 21.56% |
| 2003-09-30 | 22.76% |
| 2003-06-30 | 22.41% |
| 2003-03-31 | 14.09% |
| 2002-12-31 | 24.91% |
| 2002-09-30 | 24.55% |
